User: Guest  Login
Less Searchfields
Simple search
Title:

A phase II, randomized study of nivolumab (nivo) or nivo plus BMS-986205 with or without intravesical Bacillus Calmette-Guerin (BCG) in BCG-unresponsive, high-risk, non-muscle invasive bladder cancer (NMIBC): CheckMate 9UT.

Document type:
Meeting Abstract
Author(s):
Hahn, Noah M.; Chang, Sam S.; Meng, Maxwell; Shore, Neal D.; Konety, Badrinath R.; Steinberg, Gary D.; Gschwend, Juergen E.; Nishiyama, Hiroyuki; Redorta, Juan Palou; Taylor, John Arthur; Elegbe, Ayanbola; Lambert, Alexandre; Zhu, Li; Ishii, Yuko; Maeda, Toshiki; Raybold, Bradley; Grossfeld, Gary; Fischer, Bruce S.; Rutstein, Mark; Witjes, Alfred
Journal title abbreviation:
J Clin Oncol
Year:
2019
Journal volume:
37 Suppl S
Journal issue:
7
Fulltext / DOI:
doi:10.1200/JCO.2019.37.7_suppl.TPS493
Print-ISSN:
0732-183X
TUM Institution:
Urologische Klinik und Poliklinik
 BibTeX